Business Development, Contract Manufacturing, Genomics and RNA

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Business Development

Contract Manufacturing

Genomics

RNA

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

JULY 29, 2022

Last week, CAMP4 Therapeutics announced the close of a $100 million Series B round , which will be used to advance their regulatory RNA (regRNA)-focused programs. In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs).

RNA

RNA Gene Expression Gene Gene Therapy

The challenges and trends of cell & gene therapies

Drug Discovery World

SEPTEMBER 6, 2022

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. Research into genomic medicines is only at its infancy. Víctor Cervera-Carrascón, Tilt Bio. . Despite this the industry is still expanding.

Gene Therapy

Gene Therapy Gene Manufacturing Medicine

Clinical Research Informer

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

The challenges and trends of cell & gene therapies

Stay Connected